Butaxamine

Butaxamine
Clinical data
ATC code	None;
Identifiers
	IUPAC name (1S,2S)-1-(2,5-dimethoxyphenyl)-2-; (tert-butylamino)propan-1-ol;
CAS Number	2922-20-5 ;
PubChem CID	21909;
ChemSpider	20593 ;
UNII	0NM31M53PW;
ChEMBL	ChEMBL289093;
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.369 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cl.O(c1ccc(OC)cc1C(O)C(NC(C)(C)C)C)C;
	InChI InChI=1S/C15H25NO3.ClH/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6;/h7-10,14,16-17H,1-6H3;1H ; Key:URPAECSKKQLCII-UHFFFAOYSA-N ;
	(verify)

Butaxamine (INN, also known as butoxamine) is a β₂-selective beta blocker. Its primary use is in experimental situations in which blockade of β₂ receptors is necessary to determine the activity of the drug (i.e. if the β₂ receptor is completely blocked, but the given effect is still present, the given effect is not a characteristic of the β₂ receptor). It has no clinical use. An alternative name is α-(1-[tert-butylamino]ethyl)-2,5-dimethoxybenzyl alcohol.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.